SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Entasis Therapeutics Presents Data On Sulbactam-Durlobactam And Etx0462 At 2022 ASM Microbe Annual Conference

reuters.com · 06/09/2022 08:07
BRIEF-Entasis Therapeutics Presents Data On Sulbactam-Durlobactam And Etx0462 At 2022 ASM Microbe Annual Conference

- Entasis Therapeutics Holdings Inc ETTX:

  • ENTASIS THERAPEUTICS PRESENTS DATA ON SULBACTAM-DURLOBACTAM AND ETX0462 AT 2022 ASM MICROBE ANNUAL CONFERENCE

Source text for Eikon: ID:nGNX4jqN0r

Further company coverage: ETTX


((reuters.briefs@thomsonreuters.com;))